nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0851	0.126	CbGbCtD
Sufentanil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0801	0.119	CbGbCtD
Sufentanil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0801	0.119	CbGbCtD
Sufentanil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0724	0.107	CbGbCtD
Sufentanil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0724	0.107	CbGbCtD
Sufentanil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0625	0.0925	CbGbCtD
Sufentanil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0607	0.0898	CbGbCtD
Sufentanil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0549	0.0812	CbGbCtD
Sufentanil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0549	0.0812	CbGbCtD
Sufentanil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0526	0.0779	CbGbCtD
Sufentanil—Shivering—Saquinavir—acquired immunodeficiency syndrome	0.00726	0.0336	CcSEcCtD
Sufentanil—Laryngospasm—Delavirdine—acquired immunodeficiency syndrome	0.00407	0.0188	CcSEcCtD
Sufentanil—Apnoea—Efavirenz—acquired immunodeficiency syndrome	0.00374	0.0173	CcSEcCtD
Sufentanil—OPRM1—nerve—acquired immunodeficiency syndrome	0.00339	0.216	CbGeAlD
Sufentanil—Euphoric mood—Efavirenz—acquired immunodeficiency syndrome	0.00273	0.0126	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00263	0.0289	CbGpPWpGaD
Sufentanil—Euphoric mood—Delavirdine—acquired immunodeficiency syndrome	0.00261	0.0121	CcSEcCtD
Sufentanil—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.00257	0.0119	CcSEcCtD
Sufentanil—Euphoric mood—Ritonavir—acquired immunodeficiency syndrome	0.00241	0.0112	CcSEcCtD
Sufentanil—Euphoric mood—Saquinavir—acquired immunodeficiency syndrome	0.00232	0.0107	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00231	0.0254	CbGpPWpGaD
Sufentanil—Chills—Didanosine—acquired immunodeficiency syndrome	0.00216	0.00997	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00205	0.0225	CbGpPWpGaD
Sufentanil—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00195	0.0214	CbGpPWpGaD
Sufentanil—Urinary retention—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.00896	CcSEcCtD
Sufentanil—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00188	0.0087	CcSEcCtD
Sufentanil—Chills—Stavudine—acquired immunodeficiency syndrome	0.00187	0.00866	CcSEcCtD
Sufentanil—Chills—Abacavir—acquired immunodeficiency syndrome	0.00184	0.00853	CcSEcCtD
Sufentanil—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00182	0.00843	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00179	0.0197	CbGpPWpGaD
Sufentanil—Urinary tract disorder—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.00828	CcSEcCtD
Sufentanil—Urethral disorder—Zidovudine—acquired immunodeficiency syndrome	0.00178	0.00822	CcSEcCtD
Sufentanil—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00171	0.0079	CcSEcCtD
Sufentanil—Urinary tract disorder—Indinavir—acquired immunodeficiency syndrome	0.00167	0.0077	CcSEcCtD
Sufentanil—Urethral disorder—Indinavir—acquired immunodeficiency syndrome	0.00165	0.00765	CcSEcCtD
Sufentanil—Chills—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00753	CcSEcCtD
Sufentanil—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00158	0.0073	CcSEcCtD
Sufentanil—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.00728	CcSEcCtD
Sufentanil—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00722	CcSEcCtD
Sufentanil—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00718	CcSEcCtD
Sufentanil—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00154	0.0071	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00152	0.0166	CbGpPWpGaD
Sufentanil—Chills—Indinavir—acquired immunodeficiency syndrome	0.00151	0.007	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00147	0.0162	CbGpPWpGaD
Sufentanil—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00675	CcSEcCtD
Sufentanil—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00658	CcSEcCtD
Sufentanil—Alfentanil—ALB—acquired immunodeficiency syndrome	0.00142	1	CrCbGaD
Sufentanil—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00644	CcSEcCtD
Sufentanil—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00642	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00138	0.0152	CbGpPWpGaD
Sufentanil—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00639	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00137	0.0151	CbGpPWpGaD
Sufentanil—Chills—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00633	CcSEcCtD
Sufentanil—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00137	0.00631	CcSEcCtD
Sufentanil—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00137	0.00631	CcSEcCtD
Sufentanil—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00624	CcSEcCtD
Sufentanil—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.0062	CcSEcCtD
Sufentanil—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00615	CcSEcCtD
Sufentanil—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00614	CcSEcCtD
Sufentanil—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00133	0.00613	CcSEcCtD
Sufentanil—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00611	CcSEcCtD
Sufentanil—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00132	0.0061	CcSEcCtD
Sufentanil—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.0013	0.00601	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00129	0.0142	CbGpPWpGaD
Sufentanil—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00596	CcSEcCtD
Sufentanil—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00127	0.00585	CcSEcCtD
Sufentanil—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00585	CcSEcCtD
Sufentanil—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00126	0.00582	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00124	0.0136	CbGpPWpGaD
Sufentanil—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00123	0.00567	CcSEcCtD
Sufentanil—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00563	CcSEcCtD
Sufentanil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00561	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00121	0.0133	CbGpPWpGaD
Sufentanil—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00121	0.00559	CcSEcCtD
Sufentanil—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.0012	0.00557	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0012	0.0132	CbGpPWpGaD
Sufentanil—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00554	CcSEcCtD
Sufentanil—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.0012	0.00554	CcSEcCtD
Sufentanil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00119	0.00551	CcSEcCtD
Sufentanil—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00546	CcSEcCtD
Sufentanil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00118	0.00546	CcSEcCtD
Sufentanil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00118	0.00546	CcSEcCtD
Sufentanil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00544	CcSEcCtD
Sufentanil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00117	0.00543	CcSEcCtD
Sufentanil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00542	CcSEcCtD
Sufentanil—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00537	CcSEcCtD
Sufentanil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00115	0.00534	CcSEcCtD
Sufentanil—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0053	CcSEcCtD
Sufentanil—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00115	0.0053	CcSEcCtD
Sufentanil—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00528	CcSEcCtD
Sufentanil—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00113	0.00523	CcSEcCtD
Sufentanil—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00521	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00112	0.0123	CbGpPWpGaD
Sufentanil—OPRD1—nervous system—acquired immunodeficiency syndrome	0.00112	0.0711	CbGeAlD
Sufentanil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00111	0.00515	CcSEcCtD
Sufentanil—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00511	CcSEcCtD
Sufentanil—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.00507	CcSEcCtD
Sufentanil—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00505	CcSEcCtD
Sufentanil—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00109	0.00505	CcSEcCtD
Sufentanil—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00109	0.012	CbGpPWpGaD
Sufentanil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00109	0.00502	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00109	0.0119	CbGpPWpGaD
Sufentanil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00502	CcSEcCtD
Sufentanil—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.00108	0.0685	CbGeAlD
Sufentanil—Rash—Didanosine—acquired immunodeficiency syndrome	0.00108	0.00498	CcSEcCtD
Sufentanil—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00498	CcSEcCtD
Sufentanil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00108	0.00497	CcSEcCtD
Sufentanil—OPRK1—nervous system—acquired immunodeficiency syndrome	0.00107	0.0682	CbGeAlD
Sufentanil—Headache—Didanosine—acquired immunodeficiency syndrome	0.00107	0.00495	CcSEcCtD
Sufentanil—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00493	CcSEcCtD
Sufentanil—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00491	CcSEcCtD
Sufentanil—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.0049	CcSEcCtD
Sufentanil—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00489	CcSEcCtD
Sufentanil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00487	CcSEcCtD
Sufentanil—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00485	CcSEcCtD
Sufentanil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0664	CbGeAlD
Sufentanil—OPRD1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00104	0.0115	CbGpPWpGaD
Sufentanil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00478	CcSEcCtD
Sufentanil—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.00103	0.0656	CbGeAlD
Sufentanil—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00103	0.0113	CbGpPWpGaD
Sufentanil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.00472	CcSEcCtD
Sufentanil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00471	CcSEcCtD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00102	0.0112	CbGpPWpGaD
Sufentanil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00101	0.00469	CcSEcCtD
Sufentanil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00468	CcSEcCtD
Sufentanil—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00467	CcSEcCtD
Sufentanil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00466	CcSEcCtD
Sufentanil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000988	0.00457	CcSEcCtD
Sufentanil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000984	0.00455	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000983	0.0108	CbGpPWpGaD
Sufentanil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000981	0.00453	CcSEcCtD
Sufentanil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000978	0.00452	CcSEcCtD
Sufentanil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000977	0.00452	CcSEcCtD
Sufentanil—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000972	0.0045	CcSEcCtD
Sufentanil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000968	0.00448	CcSEcCtD
Sufentanil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000967	0.00447	CcSEcCtD
Sufentanil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000966	0.00447	CcSEcCtD
Sufentanil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000963	0.00445	CcSEcCtD
Sufentanil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000962	0.00445	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000949	0.0104	CbGpPWpGaD
Sufentanil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000948	0.00438	CcSEcCtD
Sufentanil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000946	0.00437	CcSEcCtD
Sufentanil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000943	0.00436	CcSEcCtD
Sufentanil—OPRM1—blood—acquired immunodeficiency syndrome	0.000941	0.0597	CbGeAlD
Sufentanil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000938	0.00434	CcSEcCtD
Sufentanil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000937	0.00433	CcSEcCtD
Sufentanil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000936	0.00433	CcSEcCtD
Sufentanil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000935	0.00432	CcSEcCtD
Sufentanil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000934	0.00432	CcSEcCtD
Sufentanil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000933	0.00432	CcSEcCtD
Sufentanil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000932	0.00431	CcSEcCtD
Sufentanil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000929	0.0043	CcSEcCtD
Sufentanil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000929	0.00429	CcSEcCtD
Sufentanil—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000928	0.00429	CcSEcCtD
Sufentanil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000921	0.00426	CcSEcCtD
Sufentanil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00092	0.00425	CcSEcCtD
Sufentanil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.00425	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000918	0.0101	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000916	0.0101	CbGpPWpGaD
Sufentanil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000915	0.00423	CcSEcCtD
Sufentanil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000912	0.00422	CcSEcCtD
Sufentanil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000912	0.00422	CcSEcCtD
Sufentanil—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000906	0.0576	CbGeAlD
Sufentanil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000901	0.00417	CcSEcCtD
Sufentanil—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.000895	0.00983	CbGpPWpGaD
Sufentanil—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.000895	0.00983	CbGpPWpGaD
Sufentanil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000895	0.00414	CcSEcCtD
Sufentanil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000893	0.00413	CcSEcCtD
Sufentanil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000891	0.00412	CcSEcCtD
Sufentanil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000884	0.00409	CcSEcCtD
Sufentanil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000883	0.00408	CcSEcCtD
Sufentanil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000881	0.00407	CcSEcCtD
Sufentanil—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.000871	0.00957	CbGpPWpGaD
Sufentanil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000868	0.00401	CcSEcCtD
Sufentanil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00086	0.00398	CcSEcCtD
Sufentanil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000857	0.00396	CcSEcCtD
Sufentanil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000857	0.00396	CcSEcCtD
Sufentanil—OPRD1—brain—acquired immunodeficiency syndrome	0.000856	0.0544	CbGeAlD
Sufentanil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000852	0.00394	CcSEcCtD
Sufentanil—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000848	0.00392	CcSEcCtD
Sufentanil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000834	0.00386	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000832	0.00913	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000831	0.00913	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00083	0.00912	CbGpPWpGaD
Sufentanil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000826	0.00382	CcSEcCtD
Sufentanil—OPRK1—brain—acquired immunodeficiency syndrome	0.00082	0.0521	CbGeAlD
Sufentanil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000819	0.00379	CcSEcCtD
Sufentanil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000818	0.00378	CcSEcCtD
Sufentanil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000813	0.00376	CcSEcCtD
Sufentanil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000812	0.00375	CcSEcCtD
Sufentanil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000807	0.00373	CcSEcCtD
Sufentanil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000801	0.0037	CcSEcCtD
Sufentanil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000798	0.00369	CcSEcCtD
Sufentanil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000795	0.00367	CcSEcCtD
Sufentanil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000793	0.00366	CcSEcCtD
Sufentanil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000792	0.00366	CcSEcCtD
Sufentanil—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000774	0.0085	CbGpPWpGaD
Sufentanil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000767	0.00354	CcSEcCtD
Sufentanil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000766	0.00354	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000765	0.00841	CbGpPWpGaD
Sufentanil—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000764	0.0485	CbGeAlD
Sufentanil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000762	0.00353	CcSEcCtD
Sufentanil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000762	0.00352	CcSEcCtD
Sufentanil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000758	0.00351	CcSEcCtD
Sufentanil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000756	0.00349	CcSEcCtD
Sufentanil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000755	0.00349	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000752	0.00825	CbGpPWpGaD
Sufentanil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000751	0.00347	CcSEcCtD
Sufentanil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.00346	CcSEcCtD
Sufentanil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.00341	CcSEcCtD
Sufentanil—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000735	0.0467	CbGeAlD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000729	0.008	CbGpPWpGaD
Sufentanil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000727	0.00336	CcSEcCtD
Sufentanil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00072	0.00333	CcSEcCtD
Sufentanil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.00331	CcSEcCtD
Sufentanil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000714	0.0033	CcSEcCtD
Sufentanil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000713	0.0033	CcSEcCtD
Sufentanil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000712	0.00329	CcSEcCtD
Sufentanil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000711	0.00329	CcSEcCtD
Sufentanil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000709	0.00328	CcSEcCtD
Sufentanil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000709	0.00328	CcSEcCtD
Sufentanil—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000703	0.00772	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000692	0.0076	CbGpPWpGaD
Sufentanil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000689	0.00319	CcSEcCtD
Sufentanil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000683	0.00316	CcSEcCtD
Sufentanil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000683	0.00316	CcSEcCtD
Sufentanil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000682	0.00315	CcSEcCtD
Sufentanil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000679	0.00314	CcSEcCtD
Sufentanil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000678	0.00313	CcSEcCtD
Sufentanil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000673	0.00311	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000671	0.00737	CbGpPWpGaD
Sufentanil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.00306	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000659	0.00724	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.000657	0.00722	CbGpPWpGaD
Sufentanil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.00301	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000651	0.00715	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000651	0.00715	CbGpPWpGaD
Sufentanil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000644	0.00298	CcSEcCtD
Sufentanil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.00295	CcSEcCtD
Sufentanil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000637	0.00295	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000633	0.00695	CbGpPWpGaD
Sufentanil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000632	0.00292	CcSEcCtD
Sufentanil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000631	0.00292	CcSEcCtD
Sufentanil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000628	0.0029	CcSEcCtD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000616	0.00676	CbGpPWpGaD
Sufentanil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000613	0.00284	CcSEcCtD
Sufentanil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000608	0.00281	CcSEcCtD
Sufentanil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000608	0.00281	CcSEcCtD
Sufentanil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000608	0.00281	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000607	0.00667	CbGpPWpGaD
Sufentanil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000604	0.00279	CcSEcCtD
Sufentanil—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000601	0.0066	CbGpPWpGaD
Sufentanil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000595	0.00275	CcSEcCtD
Sufentanil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000585	0.0027	CcSEcCtD
Sufentanil—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000584	0.00641	CbGpPWpGaD
Sufentanil—OPRM1—brain—acquired immunodeficiency syndrome	0.000584	0.0371	CbGeAlD
Sufentanil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00058	0.00268	CcSEcCtD
Sufentanil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00058	0.00268	CcSEcCtD
Sufentanil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000576	0.00267	CcSEcCtD
Sufentanil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000573	0.00265	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000572	0.00629	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000571	0.00627	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000571	0.00627	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000567	0.00623	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000557	0.00612	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000555	0.0061	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000549	0.00603	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000549	0.00603	CbGpPWpGaD
Sufentanil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.00253	CcSEcCtD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000542	0.00595	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000536	0.00589	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000513	0.00564	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000513	0.00563	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000512	0.00562	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00051	0.0056	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000502	0.00551	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000495	0.00544	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000482	0.0053	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000482	0.0053	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000481	0.00529	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000481	0.00529	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000475	0.00522	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00047	0.00516	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000469	0.00515	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000464	0.0051	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00045	0.00494	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000447	0.00491	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000446	0.0049	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000437	0.00479	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000437	0.00479	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000434	0.00477	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000433	0.00475	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000424	0.00466	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000418	0.00459	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000407	0.00447	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000407	0.00447	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000407	0.00447	CbGpPWpGaD
Sufentanil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000402	0.0255	CbGeAlD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000402	0.00441	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000397	0.00436	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000391	0.0043	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000391	0.00429	CbGpPWpGaD
Sufentanil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000383	0.0243	CbGeAlD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000383	0.0042	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000383	0.0042	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000381	0.00418	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000378	0.00415	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000377	0.00415	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000376	0.00413	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000367	0.00403	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000366	0.00402	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000354	0.00388	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000349	0.00384	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000344	0.00378	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000343	0.00377	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000332	0.00365	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000332	0.00365	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000332	0.00365	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000331	0.00363	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00033	0.00362	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000325	0.00357	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000324	0.00355	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000324	0.00355	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000317	0.00348	CbGpPWpGaD
Sufentanil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000311	0.0198	CbGeAlD
Sufentanil—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00031	0.00341	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00031	0.0034	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000306	0.00336	CbGpPWpGaD
Sufentanil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000299	0.019	CbGeAlD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000299	0.00329	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000294	0.00323	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000292	0.0032	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000292	0.0032	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000291	0.0032	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00029	0.00318	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000285	0.00313	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000279	0.00306	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000278	0.00305	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000262	0.00288	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000262	0.00288	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000259	0.00284	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000258	0.00283	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000253	0.00278	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000246	0.00271	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000246	0.00271	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000246	0.0027	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000241	0.00264	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000235	0.00258	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000228	0.0025	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000222	0.00244	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000222	0.00244	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000218	0.00239	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000204	0.00224	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000201	0.0022	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0002	0.00219	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.0002	0.00219	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000192	0.00211	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000192	0.00211	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000188	0.00206	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000188	0.00206	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000187	0.00206	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000181	0.00199	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000176	0.00193	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000175	0.00192	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000174	0.00191	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00187	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000171	0.00187	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000169	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000168	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000168	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000165	0.00181	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000165	0.00181	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000159	0.00175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000152	0.00167	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00015	0.00164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00015	0.00164	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000149	0.00163	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000148	0.00163	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000143	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000142	0.00156	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000142	0.00156	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000141	0.00155	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00153	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000134	0.00148	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00013	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00139	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000126	0.00139	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000125	0.00138	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000123	0.00136	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000119	0.0013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000114	0.00125	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000113	0.00124	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000112	0.00123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000107	0.00118	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000106	0.00116	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000104	0.00115	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000104	0.00114	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000103	0.00113	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000101	0.00111	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000101	0.00111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.62e-05	0.00106	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.54e-05	0.00105	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.47e-05	0.00104	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.4e-05	0.00103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.84e-05	0.000971	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.84e-05	0.000971	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.78e-05	0.000965	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.67e-05	0.000952	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.94e-05	0.000873	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.67e-05	0.000842	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.55e-05	0.00083	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.47e-05	0.00082	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.47e-05	0.00082	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.44e-05	0.000817	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	7.23e-05	0.000794	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.91e-05	0.000759	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.76e-05	0.000742	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.72e-05	0.000738	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.62e-05	0.000727	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.52e-05	0.000717	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	6.15e-05	0.000675	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.06e-05	0.000665	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.92e-05	0.000651	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.68e-05	0.000624	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.6e-05	0.000615	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.51e-05	0.000606	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.12e-05	0.000562	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.01e-05	0.00055	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.99e-05	0.000438	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000436	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.5e-05	0.000384	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.48e-05	0.000382	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.96e-05	0.000325	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.94e-05	0.000323	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.35e-05	0.000258	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.06e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.74e-05	0.000191	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.26e-05	0.000138	CbGpPWpGaD
